Virttu Biologics
Biotechnology company that pioneered the development of oncolytic viruses for treating cancer
Developer of oncolytic virus therapy for treatment of cancer. The company provides an immunotherapy product based on the Herpes Simplex Virus (HSV-1) that is designed to selectively kill cancer cells and to elicit an anti-tumor immune response in the patient.
Purchased by Sorrento Therapeutics on 28-Apr-2017
Visit website: http://www.virttu.com/
Details last updated 03-Oct-2019
Mentioned in this Resource
Sorrento Therapeutics
Biotechnology company focused on the development of proprietary drug therapeutics for addressing unmet medical needs
